These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Piglansky L, Leibovitz E, Raiz S, Greenberg D, Press J, Leiberman A, Dagan R. Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379 [Abstract] [Full Text] [Related]
6. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Dagan R, Abramson O, Leibovitz E, Lang R, Goshen S, Greenberg D, Yagupsky P, Leiberman A, Fliss DM. Pediatr Infect Dis J; 1996 Nov; 15(11):980-5. PubMed ID: 8933545 [Abstract] [Full Text] [Related]
7. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Cohen R, Levy C, de La Rocque F, Gelbert N, Wollner A, Fritzell B, Bonnet E, Tetelboum R, Varon E. Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121 [Abstract] [Full Text] [Related]
12. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. del Castillo F, Baquero-Artigao F, Garcia-Perea A. Pediatr Infect Dis J; 1998 Feb; 17(2):94-7. PubMed ID: 9493802 [Abstract] [Full Text] [Related]
14. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era. Pumarola F, Marès J, Losada I, Minguella I, Moraga F, Tarragó D, Aguilera U, Casanovas JM, Gadea G, Trías E, Cenoz S, Sistiaga A, García-Corbeira P, Pirçon JY, Marano C, Hausdorff WP. Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414 [Abstract] [Full Text] [Related]
15. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. Fenoll A, Aguilar L, Robledo O, Giménez MJ, Tarragó D, Granizo JJ, Gimeno M, Coronel P. J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681 [Abstract] [Full Text] [Related]
17. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Pediatr Infect Dis J; 2000 Nov; 19(11):1040-5. PubMed ID: 11099083 [Abstract] [Full Text] [Related]
18. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin. Fenoll A, Giménez MJ, Robledo O, Aguilar L, Tarragó D, Granizo JJ, Gimeno M, Coronel P. J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242 [Abstract] [Full Text] [Related]
20. [Antibiotic resistance of pneumococci and H. influenzae isolated from the nasopharyngeal flora of children with acute otitis media between 2006 and 2010]. Cohen R, Bingen E, Levy C, Benani M, Thollot F, Klink Z, Schlemmer C, Elbez A, Varon E. Arch Pediatr; 2011 Aug; 18(8):926-31. PubMed ID: 21664804 [Abstract] [Full Text] [Related] Page: [Next] [New Search]